Its oncogenic role involves promoting tumor proliferation and invasion by suppressing targets such as LATS2, which facilitates cell proliferation [19], and FIH, which aids in hypoxia-driven tumor progression [11]. The gene discussed is CASR; the disease is neoplasm.